Resume Review

As I hope is clear from previous posts, networking is essential to improving your ability to make an employment change.  Getting referred into a company or an endorsement via an employee submitting your resume, gets your resume a second look. Put yourself in the shoes of the recruiter reviewing resumes.

The information below was submitted to me by Dick Winokur, who I have known for 11 years.  We met when he was working for the pharmaceutical company Sanofi-Aventis (now Sanofi). When I first started FOCM Networking and launched the web site  he shared some information with me that he relied up on in his career.

WHAT SMART RESUME REVIEWERS LOOK FOR

  1. They keep the job criteria firmly in mind–look for “buzz-words.”
  2. They look for a stated job objective.
  3. They look for the “can-do” candidate.
  4. They read between the lines for the “will do” candidate.
  5. They search for consistent career advancement.
  6. They look for job results versus activities.
  7. They notice how the resume appears.

ASK YOURSELF: IF I HAD TO LOOK THROUGH 200 RESUMES IN THREE HOURS, WHAT WOULD I LOOK FOR?

Additional resources:

https://www.agbsearch.com/tips/top-10-tips-for-writing-job-winning-resume

https://www.michaelpage.com/advice/career-advice/cover-letter-and-resume-advice/how-write-winning-resume-0

Virtual Networking Meeting Summary

On December 15, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event. This was our year-end event and we didn’t have a speaker, topic or theme.

We kept everyone in one room and went around the room asking people to answer a variety of questions. We asked for each person to share what positive or memorable thing happened in 2021 and what they were looking forward to happening in 2022.

  • A representative answer was that while some had caught COVID and it was a bad illness, no one had anyone in their families get severely ill or pass away from it. The outlook for 2022 was felt to be somewhat tentative with the global rise of infections due to the Omicron variant. It was noted that the annual January JP Morgan conference will be virtual again due to the rise in cases. (Occurring today, December 22, Pfizer’s oral dose anti-viral pill to treat COVID was approved.)
  • Michael Young shared that 2021 found him becoming a grandfather with the birth of grandson Oliver Kiesing Miller (pictures below attendee listing). Michael’s hopes for 2022 include completing the first draft of a book he’s writing on “Branding”. He also echoed the feelings of many of us – having the opportunity to see clients, customers and friends in person and a return to in-person conferences. (I think this is the equivalent of a blood transfusion for extroverts).
  • Ires Alliston shared that she is hosting a Female Expert Coaches Summit May 9 – 11 in Daytona Beach, FL. More information is available here: (https://femceosummit.com/).

Movies/TV shows people are watching/recommending:

  • You
  • The Unforgiveable
  • Get Back
  • Curb Your Enthusiasm
  • Giri/Haji
  • Yellowstone

Fountain pens
It turns out that Nadia Bracken has found the hobby of collecting fountain pens. Someone else on the call mentioned a former boss who also did so.  There was a discussion about the psychological draw toward collecting such pens.  I subsequently found this discussion group (https://www.fountainpennetwork.com/forum/topic/136590-pen-personality/) .The hobby appears to be more associated with introversion based on the non-controlled survey in the discussion group. Another article on the topic is: https://www.inkedhappiness.com/fountain-pen-collecting-the-psychology-behind-my-madness/

Toward the end of the event, two things occurred after some had dropped off:

  • Dan Weddle sang and played his guitar
  • Michael Young arrived and showed pictures of his adorable 1st grandson

Please join us next month on January 19

ATTENDEES (bolded names were first time attendees):
Kevin Boos, Rho
Brian Horan, SupplyRx
Wessam Sonbol, Delve Health
Michael W. Young, biomedwoRx: Life Sciences Consulting
Ires Alliston, Business Coach, Consulting & Marketing
Chris Bergey, Humphries Insurance Agency
Nadia Bracken, Medidata
Dan Weddle, AltaSciences
Mike O’Gorman, Life Science Marketplace
Patrick Champoux, SkillPad
Maria Frane, Simbec-Orion
Sara Tylosky, Farmacon
Brennan Munley, Rho
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

Photo Collection

Esteemed Industry Professionals
Revered Industry Professionals
Heralded clinical research industry professionals
Dan Weddle performing an original song
Denise, Zulma and Michael concluding the meeting
Oliver Kiesing Miller, grandson of Michael Young
Oliver Kiesing Miller, grandson of Michael Young

 

Halloween Fun

So one member of FOCM, Jack Minster, a member in good standing shared with me the fun he has at Halloween in his home town. Here is what he shared with me:

I know all the kids in my neighborhood.  However, strangers from other areas bring their kids to my neighborhood on a mission to collect as much candy as they can.  I am not kidding.  It’s a racket for these people.  So I make these little grubbers earn it.  I lure them in with real pumpkin jack-o-lanterns I carved, and interesting “scary” decorations.  But then I activate a remote control device and a very disturbing very loud animatronic ghoul pops up out of the liriope leaves (from laying to standing).  It’s shrieking with eyes blinking.  Kids scream staring at it.  But the noise from this sets off a sound-activated giant animatronic spider which leaps out immediately after, directly behind them making loud “scree” noises.  By now the kids are totally freaked.  Then by the door, rising up out of the ground come more, sound-activated even scarier ghouls saying “Welcome to our graveyard, join us…”

Groups of kids run away screaming, they just bolt, whole herds of them running back down my lawn lacking the courage to follow through and knock.  Last year a group of tween girls made it through the gauntlet of horror, knocked, and I overheard one say, “I will have nightmares from this for the rest of my life.”

November 17 Networking Event Summary

One of the things I thoroughly enjoy about networking is meeting such interesting, fascinating people with different perspectives. This helps us understand and appreciate those differences and helps us re-consider our approach to certain things.

On November 17, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event.

Whereas last month we had a featured speaker – Heather Hollick on LinkedIn best practices; this time we just had general discussion and greeting of one another. While there were still a manageable number, I introduced each person and how I know them. There was also discussion and general agreement that when Merck and Pfizer get their oral dose antiviral medicines approved (whether emergency authorization or full approval); the COVID-19 pandemic will become very manageable and the world can return to our new normal; forever impacted but less restricted. (added since the 11/17 meeting – the identification of the Omicron variant may put a slow down on the return; however, early information indicates that while it’s easily transmissible, the symptoms are different and mild, such that as of Nov 30 in South Africa hospital where the doctor found the Omicron variant, no hospitalizations are attributed to it. And now just today, an FDA Advisory panel recommended approval for Merck’s anti-viral pill to treat COVID-19 and reduce hospitalizations.)

We then moved to the evening’s agenda. We had three rooms for people to go to depending on their interests.  The three discussion topics were:

  • Clinical Trial Recruitment and Retention
  • Innovation and Technology
  • Networking

Heather Hollick chaired the Networking room. One discussion centered around how sales/business development people use it and consultant/subject matter experts use it to best fill their connection needs. Interestingly, several participants shared that they control their LinkedIn outreach and purposefully limit their contacts to a more easily managed subset (~1000) to maximize the depth of relationships. Several other participants use a more liberal approach and have grown their networks to over 10,000 contacts who then serve as “private wikis” allowing rapid access to large groups of professionals with multi-various experiences.

Please join us next month on December 15 and if you have a Christmas sweater – wear it!

ATTENDEES (bolded names were first time attendees, I think):

Heather Hollick, Rizers, LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Mike Burrows, Burrows Life Science Associates, LLC
Lacey Clements, IMA Clinical Research
Kevin Boos, Rho
Valerie Roussin-Paradis, SkillPad
Edwin Gershom, Noble Life Sciences
Wessam Sonbol, Delve Health
Michael W. Young, biomedwoRx: Life Sciences Consulting
Nicole Yoon, Mediaiplus
Ires Alliston, Business Coach, Consulting & Marketing
Lindsey Summers, Green Key Resources
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Brandon Huffman, Global Life Sciences Allianc
Holly Cliffe, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

November 17 2021 Networking Event
November Event Flyer

FOCM & GLSA Virtual Networking Meeting

One of the things I thoroughly enjoy about networking is meeting such interesting people with different perspectives. This helps us understand and appreciate those differences and helps us re-consider our approach to certain things.

On October 20, the Global Life Sciences Alliance along with FOCM Networking held its monthly pharmaceutical/biotech/clinical research/medical device/drug development industry online networking event (that’s a sentence-full). I know I wrote that in last month’s minutes too, so I promise to acronymize/shorten/bitly it next month, maybe to Pharma/Bio/CRO/Med & DrugDev or PBCMD? Is there a broader term one of you readers can suggest?

While people were arriving into the Zoom room, the first arrivers greeted each other and got their headsets, earphones, etc ready and connected. We started with the acknowledgement that October is National Breast Cancer Awareness Month. The advances in cancer therapies over the past dozen years or so is truly remarkable. With genotyping advances, new drugs are designed/created that work very well.  This allows testing to be done prior to drug administration and know ahead of time that certain patients will respond well.  So instead of having to enroll 300 cancer patients in a study to get enough with the defect in order to show statistical significance, the study can be done with fewer patients and to show significance and speed up the time to FDA approval.

We then moved to our featured speaker, Heather Hollick, a friend of mine for several years and the author of “Helpful, A Guide to Life, Careers and the Art of Networking”. Heather focused the discussion on best practices for using LinkedIn. It is an invaluable tool for networking. There are 8 ways that LinkedIn is beneficial.

  1. LinkedIn is how you present yourself to the industry. At a minimum it is your online resume.
  2. Enhances introductions – you know so much more about who you’re being introduced to.
  3. Refreshes your memory on who a person is, where you know them from and how long you’ve been connected.
  4. It helps you prepare for meetings – review who will be in the meeting and find items of commonality.
  5. Find companies that are hiring
  6. Provides links to other websites aiding in your research
  7. Keep track of who is in your network.
  8. Engage in groups and discussions with others that you share interest with.

I like to include how I met people, as a demonstration of the power and benefits of networking. I was connected to Heather via Tanyss Mason. I admit I’m having a difficult time remembering how Tanyss and I first became connections. Heather was in the midst of writing the book when we first met over the phone. When the book was released and Heather was in the RTP, NC area at a book premier and signing event we got to meet in person. Heather co-presented at the 2021 DIA Annual meeting (virtual) with me on a Networking workshop. We’ll collaborate again on this session for the DIA 2022 meeting being held in Chicago.

We typically go into several breakout sessions of 3-4 attendees for about 12 minutes each but this time, there was so much good discussion about LinkedIn and maintaining, nurturing and freshening one’s network that we showed our flexibility and kept rolling with the topic of interest.

Please join us next month on November 17.

ATTENDEES (bolded names were first time attendees, I think):

Heather Hollick, Rizers, LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Mike Burrows, Burrows Life Science Associates, LLC
Lacey Clements, IMA Clinical Research
Nadia Bracken, Medidata
Christine Narro, Medical Device Co.
Lewis Kelly, Gunvatta
Chris Bergey, Humphries Insurance Agency
Michael O’Gorman, Life Science Marketplace
Patrick McCarthy, ValidCare
Joe Dustin, Transcelerate Biopharma
Janie St. Pierre, Accellacare
Ellen Bedenko, IQVia
Patrick Champoux, SkillPad
Andrew Mulchinski, Symbio Research
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Daryl Oberg, Global Life Sciences Alliance
Brandon Huffman, Global Life Sciences Alliance
Holly Cliffe, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

Screen shot of virtual networking event

Support FOCM Entrepreneur

I am excited to announce that, Alicia Kelley Schifano, the first graduate of the FOCM College of Entrepreneurism is hitting the big time!!  Alicia will be a contestant on a new TV show airing Thursday, October 14th on the USA Network.  The show is America’s Big Deal.  It was created by Joy Mangano (from the movie Joy) and it will be hosted by Scott Evans from Access Hollywood!  It will be a bit like Shark Tank but live and “shoppable” so people can buy the products in real time while watching the show.  Alicia will be on the first episode, competing for a retail deal for the Mr. Big Curling Irons!  Here is a link to the video promo: https://youtu.be/t3xJYFU8ugc

Here’s a link to the contestant page:

Please tune in at 9pm, October 14th and watch Alicia shine! And check out the product being offered at a $20 discount at the above link. For any of the FOCM members with long hair, this curling iron is a must in your beauty supplies inventory.  https://www.mrbigcurlingirons.com/

I have known Alicia for more than 10 years, having been introduced to her via TommiLynn Baker.  At our first meeting we talked for hours.  Alicia is energizing to be around; so much energy, passion and enthusiasm.

Meeting Summary of FOCM & GLSA Event

So, it finally happened, on that glorious day which shall long be remembered, these minutes will be heretofore submitted to the USA Library of Congress, the Smithsonian Institute and for reasons unknown, to the Sydney Opera House on the northside bulletin board for public postings.

On May the 20, in the year 2021 of the Gregorian calendar, it was noted that the GLSA (Global Life Sciences Alliance) and FOCM (Friends of Chris Matheus) Networking organization did hold an online (virtual) networking event. The meticulously planned event went terribly awry when but half of the positive RSVPs failed to show up.  That said, it was a resounding success for the initial such event.  A total of 22 attended.

The meeting started off with an acknowledgement that it was Global Clinical Trials Day and a toast was given to the clinical research industry for saving the world from Covid-19 and to James Lind, the Scottish doctor who initiated the first controlled randomized clinical trial on May 20, 1747 aboard a sailing ship. Dr. Lind divided twelve sailors sick with scurvy into six groups of two. They all received the same diet but, in addition, each group was given a different treatment. Only the two sailors who received citrus fruits improved and returned to work.

Chris then introduced the GLSA members to the FOCM community.  After a bit of general discussion, several polls were taken. About half of the group is reluctant to resume conference travel immediately, preferring to wait a few more months. Slightly more than half have been vaccinated or acquired immunity through catching the virus. An interesting opinion was voiced that perhaps as members of the clinical research industry, we should set the example by all being vaccinated.  I, for one and I believe I speak for many of the others have the utmost confidence that not a step was missed, not a shortcut taken in the development of the available vaccines.  Given the prioritization and urgency of vaccine development, we were able to speed up the data review process. The one thing that the sped up development lacked is longer term safety and side effect data.  However, vaccine side effects rarely (I can’t think of any) change the longer from the time of injection.

Then it was time for speed networking!  The assertion has been made by Chris that each of us in the clinical research industry are within 2 degrees of separation from each other. We had 4 different sessions.  Attendees were randomly put into different “rooms” with the assignment to each introduce themselves to the group, sharing where they’d worked the previous 10-20 years and what they’re doing now to see if they could identify who they knew in common.  Good information was exchanged and several new connections were made which can improve the management of clinical trials.

Join us next month – June 16.

Attendees:
David Holland, Cmed Research
Jon Matheus, Pancrazi Real Estate
Sheila Mahoney-Jewels, Life Science Hub
Eric Nier, Block Clinical
Lynne Becker, Power of Patients
Nadia Bracken, Medidata
Christine Ver Straate, GLSA
Mitchell Efros, Verified Clinical Trials
Cassandra Hui, HealMary
Denise McNerney, GLSA
Joe Buser, GLSA
Tom Ryan, GLSA
Kalyan Ghosh, Inference Inc
Marty Frazier, GLSA
Tanusree Bhattacharyya, Inference Inc
Zulma Varela, GLSA
Mike O’gorman, Life Science Marketplace
David Gibboni, DJGibboni Consulting
Eric Mayer, EDP Biotech
Craig Fernandes, EDP Biotech
Maria Frane, C3 Research

Office Dress Code Rules – A Look Back

So way back in 2006 working with a great group of folks in starting a Raleigh area office for a global organization, we were a somewhat rebellious and humorous group. When HR in Headquarters would send out policies, we’d create our own version for our office, as shown in the example below: (last names have been left out to protect people’s identities)

DRESS CODE

An employee’s professional appearance is very important.  It reflects a respect for ourselves as well as for the people we are serving.  Your appearance says a lot about you and is an important part of your performance appraisal.  Therefore, all employees of the Company are expected to dress appropriately in a professional, clean, businesslike, well-groomed manner.  The Company has adopted certain days as “Business Casual” and “Dress down Days.”  Employees are permitted to dress accordingly within the defined guidelines.  Styles that are currently fashionable may not be appropriate for work.  Accessories, hosiery, jewelry and perfume or scented cosmetic use should be conservative.  Noncompliance with the standards of dress as stated in this policy may result in disciplinary action up to and including dismissal.

Business Dress:  To be worn at sites and as required by management in the office.  Conservative suits, ties, dresses and professional coordinated pantsuits.

Business Casual:  Usually acceptable Monday – Thursday.  Clothing that is neat and professional, such as slacks, sport shirts, casual dresses, and shirts, cream or white pants with shades of pastel blue blouses (which can be worn daily), split skirts or skorts of an appropriate length.  No jeans (except for Chris M), chacos, flipflops (faux rainbows are okay for Chris L), lounge/pajama pants (except for Kourtney when she uses the barely believable skin rash excuse), basketball shoes, kickball shoes, pants that unzip to become shorts (except for Lori), baseball caps (unless worn backwards) or leggings. 

Dress Down Day:  Usually each Friday, except for NC office where it appears that everyday is Dress Down Day.  Acceptable: Neat “dress jeans” with no holes, rips or tears (Heather), neat clean sneakers or casual shoes.  During warmer weather, conservative sandals, walking length shorts (Bermuda length shorts, and Capri pants are permitted. Maternity umbro shorts with expandable waistband are okay for Lori.

Not appropriate:  Baseball caps, motorcycle helmets (Mike), tee shirts, tank tops, gym clothes, Umbro-type shorts (Lori), cutoff shorts or shirts, tank tops, flip-flops, chacos (Heather), water shoes, Chewbacca costume (except for Greg), thongs (flip-flops), beach slides, swimsuits, bandannas, bathrobes, lingerie, hockey jerseys (except for Kristy) cowboy boots while wearing shorts, black mid-calf socks with plaid Bermuda shorts or with any shorts for that matter, dress shoes with jeans, belt with your name on it, shirts with sayings or slogans that others, not Mike, may find offensive.  An exception is Mike’s Pink Salmon slogan shirt, because that’s just too damn funny, while being totally inappropriate.

Joke: Duck walks into a bar

A duck walks into a pub and orders a pint of beer and a ham sandwich.

The barman looks at him and says, “Hang on! You’re a duck.”

“I see your eyes are working,” replies the duck.

“And you can talk!” Exclaims the barman.

“I see your ears are working, too,” Says the duck. “Now if you don’t mind, can I have my beer and my sandwich please?”

“Certainly, sorry about that,” says the barman as he pulls the duck’s pint.

“It’s just we don’t get many ducks in this pub.. What are you doing round this way?”

“I’m working on the building site across the road,” Explains the duck.  “I’m a plasterer.”

The flabbergasted barman cannot believe the duck and wants to learn more, but takes the hint when the duck pulls out a newspaper from his bag and proceeds to read it.

So, the duck reads his paper, drinks his beer, eats his sandwich, bids the barman good day and leaves.

The same thing happens for two weeks.

Then one day the circus comes to town.

The ringmaster comes into the pub for a pint and the barman says to him, “You’re with the circus, aren’t you? Well, I know this duck that could be just brilliant in your circus. He talks, drinks beer, eats sandwiches, reads the newspaper and everything!”

“Sounds marvelous,”says the ringmaster, handing over his business card.

“Get him to give me a call.”

So the next day when the duck comes into the pub the barman says, “Hey Mr. Duck, I reckon I can line you up with a top job, paying really good money.”

“I’m always looking for the next job,” Says the duck.

“Where is it?”

“At the circus,” says the barman.

“The circus?” Repeats the duck.

“That’s right,” replies the barman.

“The circus?” The duck asks again, “with the big tent?”

“Yeah,” the barman replies.

“With all the animals who live in cages, and performers who live in caravans?” says the duck.

“Of course,” the barman replies.

“And the tent has canvas sides and a big canvas roof with a hole in the middle?” persists the duck.

“That’s right!” says the barman.

The duck shakes his head in amazement, and says .. ………
.

.

.

.

.

.

“Why the hell would they need a plasterer??!”

FOCM Networking Person of the Year for 2020

Without a doubt the work done by the pharmaceutical, biotech, clinical research, drug development industry and the Food and Drug Administration is worthy of this distinction for 2020. What was accomplished is just short of miraculous.

The federal government (FDA) and the corporations cut no corners. I have no doubt that everything was done according to established good clinical principles. What was done was the speeding up of the regulatory processes; decreasing the workflow processing time. Turn around time on data review and decision making was the focus. The researchers and the reviewers of the data had Covid-19 treatments and vaccines at the forefront of their priorities.

The typical time for vaccine development to get approved is 4 years. The first two approved were done within 12 months!! There are several more in development.

We are now beginning to see the impact the vaccine is having in the decline of daily new cases. Many people have now received their second dose.

The United Kingdom began vaccinating their population one week earlier than the US and you can see the impact to their daily new cases as well. This has me very encouraged. I’m hopeful that by Memorial Day, we’ll be back to dining out and meeting in person, traveling to conferences, vacations, etc.